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Background: Systemic lupus erythematosus (SLE) is known to present with a wide variety of clinical manifestations.
Lymphadenopathy is frequently observed in children with SLE and may occasionally be the presenting feature. SLE
presenting with granulomatous changes in lymph node biopsy is rare. These features may also cause diagnostic
confusion with other causes of granulomatous lymphadenopathy.
Case presentation: We report 12 year-old female who presented with generalized lymphadenopathy associated
with intermittent fever as well as weight loss for three years. She also had developed anasarca two years prior to
presentation. On presentation, she had growth failure and delayed puberty. Lymph node biopsy revealed
granulomatous features. She developed a malar rash, arthritis and positive ANA antibodies over the course of next
two months and showed WHO class II lupus nephritis on renal biopsy, which confirmed the final diagnosis of SLE.
She was started on oral prednisolone and hydroxychloroquine with which her clinical condition improved, and she
is currently much better under regular follow up.
Conclusion: Generalized lymphadenopathy may be the presenting feature of SLE and it may preceed the other
symptoms of SLE by many years as illustrated by this patient. Granulomatous changes may rarely be seen in lupus
lymphadenitis. Although uncommon, in children who present with generalized lymphadenopathy along with
prolonged fever and constitutional symptoms, non-infectious causes like SLE should also be considered as a
diagnostic possibility.
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Generalized lymphadenopathy along with fever is com-
monly encountered in pediatric clinical practice. Infec-
tions, malignancy and connective tissue diseases are
diverse groups of illnesses causing generalized lymphaden-
opathy with fever. The majority of these are infectious in
origin and may be self limiting [1]. Although not included
in the American College of Rheumatology (ACR) diagnos-
tic criteria for systemic lupus erythematosus (SLE), gener-
alized lymphadenopathy is frequently observed in children
with SLE and may be the presenting feature in the absence
of other clinical manifestations. This may pose a diagnos-
tic dilemma, and therefore a lymph node biopsy is war-
ranted in this subset of patients.* Correspondence: devendra.shrestha@gmail.com
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reproduction in any medium, provided the orThe exact etiology of SLE is still unclear, although
multifactorial interaction with genetic and environmen-
tal factors has been implicated. It is characterized by the
formation of autoantibodies to various components of
the cell nucleus leading to inflammation, vasculitis and
immune complex deposition. Immune complex depos-
ition along with complement activation has been postu-
lated for various manifestations of SLE including lupus
nephritis, which is also demonstrated by frequent associ-
ation of hypocomplementemia and signs of vasculitis at
the sites of active SLE [2].
Few early reports have described non-caseating epi-
thelioid cell granulomas in necropsy specimens of ser-
ous membranes, lung, lymph node, and spleen [3,4] as
well as pleural biopsy specimen of a patient with SLE
[5]. Granuloma formation in SLE is rare and the patho-
genesis is unclear. Here in, we report an adolescentl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adenopathy with granulomatous features with a final
diagnosis of SLE.Case presentation
A 12 year-old girl presented to KIST Medical College
Teaching Hospital in 2011 with complaints of painless
lymph node swelling in bilateral neck and axillae for
three years, along with a history of weight loss, general-
ized weakness, and fever. However, there was no history
of joint pain, skin rash, edema, hematuria, or bone pain
at the presentation. There was no contact history of tu-
berculosis, and there was no history of similar illness or
of autoimmune diseases in the family.
In 2008, she was evaluated at another hospital for
lymphadenopathy which showed reactive changes in fine
needle aspiration cytology (FNAC) and no further treat-
ment was instituted. She had developed generalized
swelling of her body in 2009 for which she was evaluated
at a different institute and improved after taking oral
medications for one month. However, detailed medical
records were not available.
On examination, she was febrile, BP 100/60 mm Hg
and was pale. There were multiple enlarged lymph nodes
in both cervical, axillary and inguinal regions which were
soft, non tender and discrete with the largest measuring
5 cm × 5 cm in diameter. She had hepatosplenomegaly,
but there was no edema, skin rash, or bone tenderness.
Her BMI was 14.03 (below 3rd percentile) and she was















































Figure 1 Flow diagram of diagnostic work up.She was evaluated keeping diagnostic possibilities of
tuberculosis, HIV, connective tissue disease, lymphoma,
and sarcoidosis as shown in Figure 1. Her investigations
revealed as follow (Table 1).
Abdominal ultrasonography showed multiple mesen-
teric lymph nodes, the largest measuring 17 mm × 10 mm
in diameter with no ascites. Her chest x-ray and bone
marrow aspiration cytology were normal.
FNAC of cervical lymph node was suggestive of granu-
lomatous lymphadenopathy (Figure 2). Excisional biopsy
of cervical lymph node on H & E staining showed intact
capsule and lymph nodal architecture was partially
effaced by epithelioid granuloma admixed with several
eosinophils, lymphocytes and plasma cells. Other areas
showed lymphoid follicles with prominent germinal cen-
ter. The paracortical area showed an exaggeration of
high endothelial venules (Figure 3). Ziehl Neelsen stain-
ing as well as Acid Fast Bacilli (AFB) culture of the
lymph nodes was negative. Immunohistochemistry study
of lymph node was not available.
She was suspected to have brucellosis on the basis of
serology and was treated accordingly. However, she con-
tinued to have fever and persistent lymphadenopathy.
She was admitted in the pediatric ward several times
over a two months period. During the last hospital stay,
she developed a malar rash extending to nasal bridge
sparing nasolabial fold along with arthritis of small joints
of both hands (Figure 4).
On renal biopsy, there was normal cellularity, absence
of sclerosis, crescents and blood vessel thickening in
































Appearance of malar rash and 
arthritis of small joints of hands








Hemoglobin 9.2 gm/dl 10.5 gm/dl
TLC 6300/mm3 6800/mm3
DLC N70 L28 E2 N 81 L19
Platelet 478000/mm3 359000/mm3
ESR 61 mm at 1 hour 56 mm at 1 hour




Urinanalysis Albumin trace, no RBC Albumin trace,
no RBC




HIV serology Non reactive
ANA Negative Positive





LE cell preparation Negative







Serum Calcium 9.2 mg/dl
Figure 2 Photomicrograph of FNAC of a cervical lymph node.
FNAC smear showing clusters of epithelioid cells in a lymphoid
background (Wright stain, X100).
Figure 3 Photomicrograph of a cervical lymph node biopsy.
Lymph node biopsy showing epithelioid granuloma admixed with
eosinophils, lymphocytes and plasma cells (H&E stain, X40). Inset
showing epithelioid granuloma in higher magnification (H&E stain, X400).
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seen in immunofluorescence microscopy which sug-
gested the diagnosis of lupus nephritis (pure mesangial
alterations), WHO class II. Anti-Sm antibody level was
not available.
Thus the final diagnosis of SLE was made and treat-
ment was started with oral prednisolone and hydroxy-
chloroquine. Malar rash disappeared a few days after
initiation of steroid treatment. On subsequent follow up
after two weeks, lymph nodes size drastically reduced,
hepatosplenomegaly size was decreased, and constitu-
tional symptoms had also improved. She was kept under
close follow up on maintenance prednisolone. However,
on subsequent follow up, she had persistent non-Figure 4 Photograph showing erythematous malar rash
sparing nasolabial fold.
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level (42.3 mg/dl) and high ESR without flaring up of
other symptoms. After ruling out noncompliance to ster-
oid therapy, possibility of progression of lupus nephritis
or incorrect initial staging was suspected. Hence, repeat
renal biopsy was considered in March 2013 and histo-
pathology showed features of glomerulopathy exhibiting
segmental mild increase in mesangial cellularity and
matrix. Direct immunofluorescence studies revealed
mesangial granular staining with dominance of IgA, and
similar less intense staining for other immunoglobulins
and light chain components. Staining for C3 and C1q
was weak in glomerular mesangial areas. This was con-
sistent with mesangial lupus nephritis, Class II (ISN/
RPS). She is presently on maintenance prednisolone and
on regular follow up.
Conclusions
SLE is a chronic autoimmune disorder which is charac-
terized by inflammation of blood vessels and connective
tissue involving multiple systems and presence of circu-
lating autoantibodies especially ANA and Anti-dsDNA
antibodies. SLE is relatively uncommon in children and
estimated incidence ranges from 10 to 20 per 100 000
children depending on the ethnic population [6].
Children and adolescents represent 15-20% of all pa-
tients with SLE [7]. Females are affected three to five
times more often than males [8]. SLE is well known to
present with a wide variety of clinical manifestations.
Children with SLE may present with constitutional
symptoms (fatigue, myalgia, weakness, weight loss), skin
rashes, especially malar rash or arthralgia/arthritis that
may precede the detection of organ-specific lesion [8].
Prevalence of lymphadenopathy has been reported in
23-34% of patients with SLE [9] with a female prepon-
derance [10]. Despite being frequent manifestation,
lymphadenopathy is not included in the ACR criteria for
the diagnosis of SLE. Lymphadenopathy has even been
reported as the first clinical manifestation of SLE in chil-
dren [11-14]. Lymphadenopathy is very common in chil-
dren due to variety of etiologies and hence may pose a
delay in the diagnosis of SLE.
Lymph nodes in SLE are usually soft, non tender, mo-
bile, generalized and of varying size [15,16]. We also ob-
served similar findings in our patient. On histopathology,
coagulative necrosis with hematoxylin bodies is specific to
lupus lymphadenitis but is rarely observed [10]. More
commonly lymph node biopsies in SLE show reactive fol-
licular hyperplasia which is considered a nonspecific fea-
ture. Atypical lymphoproliferation found in the lymph
node biopsies of SLE were classified as reactive follicu-
lar hyperplasia with giant follicles, aspects similar to
Castelman’s disease, atypical paracortical hyperplasia
with lymphoid follicles, and atypical immunoblastic andlymphoplasmacytic proliferation [10]. A classification sys-
tem with three patterns of histopathological features of
lupus lymphadenitis had been proposed, however they did
not appear to be highly specific for SLE [17]. The occur-
rence of variety of histopathological features poses diag-
nostic difficulty and should be differentiated from
lymphoproliferative disorders. This patient had undergone
bone marrow examination which was normal.
The histopathological feature of lymph node in our pa-
tient was epithelioid granuloma admixed with several
eosinophils, lymphocytes and plasma cells along with
other areas showing features of reactive lymphadenitis.
Earlier reports described non-caseating epithelioid cell
granulomas consisting of central zone of epithelioid cells
surrounded by dense infiltrate of histiocytes without
giant cells in necropsy specimens of patients with SLE
[3,4]. Similarly several granulomas consisting of large ep-
ithelioid cells and histiocytes with granular and fibrinoid
appearance in the center without caseation were ob-
served in a pleural biopsy of a patient with SLE [5]. The
presence of granuloma in lymph node biopsy and FNAC
is suggestive of tuberculosis which is highly prevalent in
our geographical region. However there was no caseous
necrosis or Langhan type of multinucleated giant cells
that are usually seen in tubercular lymph node histo-
pathology. Furthermore, Ziehl Neelsen stain for AFB
and AFB cultures were negative in this patient. Hence
tuberculosis was considered unlikely and sequential evo-
lution of features confirmed SLE in this patient. How-
ever, there are cases where anti-tubercular treatment has
been initiated in patient with lupus lymphadenopathy
when there was a sequential absence of symptoms [14].
Lupus nephritis is considered a risk factor for tubercu-
losis and some patients develop disseminated tubercu-
losis even before use of corticosteroids [18]. This patient
did not receive anti-tubercular treatment and did not
develop flare up of symptoms in spite of corticosteroid
treatment. Therefore, the possibility of tuberculosis was
considered highly unlikely in this patient.
With the presence of a non-caseating granuloma, the
other possible diagnosis was sarcoidosis. However, serum
calcium level was normal and confluent granulomas,
multinucleated giant cells containing Schaumann bodies,
and Asteroid bodies were not seen in this patient [19].
Skin biopsy was not considered as malar rash in this pa-
tient was very typical of SLE. In addition, renal biopsy
also confirmed lupus nephritis.
Pathogenesis of granuloma formation in SLE is still
unclear. It was regarded as a response to tissue injury
and considered as a manifestation of allergic tissue reac-
tion [3]. Although SLE is considered type III hypersensi-
tivity reaction which has been extensively studied in
patients with lupus nephritis, type IV mediated mechan-
ism also may play a role in autoimmune nephritis [20].
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pression of IFN-γ and IL-12, as well as exacerbation of
lupus disease after administration of IFN-γ to NZB/
W F1 mice [21-23].
Defective clearance of apoptotic bodies by the comple-
ment system along with a reduced number of macro-
phages and capacity for phagocytosis lead to a high level
of apoptotic bodies in patients with SLE [24-26]. Hence,
persistence of these apoptotic bodies may stimulate
granuloma formation.
Formation of granuloma occurs in response to a persist-
ent stimulus and has also been linked with TNF and
induction of host matrix metalloproteinase (MMPs) pro-
duction in tuberculosis [27]. Animal studies showed
proliferative glomerulonephritis was associated with infil-
trating kidney macrophages, renal expression of IFN-
inducible genes and MMPs which were mediated IFN
[28]. Granuloma formation in SLE may be due to persist-
ence of apoptotic bodies and/or various cytokines and
MMPs. It may also support the role of type IV mediated
injury in the pathogenesis of SLE. However, detailed stud-
ies are needed.
The association of lymphadenopathy with severe dis-
ease activity, more constitutional symptoms as well as
hepatomegaly and splenomegaly has been correlated in
patients with SLE [9], which was also noted in this
patient.
All the symptoms of SLE required to fulfill ACR cri-
teria may not appear at the same time, and it took al-
most three years from initial presentation of generalized
lymphadenopathy to reach the final diagnosis and insti-
tute definite treatment for SLE in this patient. Hence,
strong clinical suspicion and close follow up is essential
for early diagnosis and treatment as well as to improve
outcomes in children with SLE. In conclusion, general-
ized lymphadenopathy may be the presenting feature of
SLE and it may preceed other symptoms of SLE by many
years as illustrated by this patient. Reactive follicular
hyperplasia is commonly observed on histopathology of
lymph nodes in SLE, and on rare occasions, there may
be presence of granulomas in lymph node biopsies.
Pathogenesis of this granuloma formation is still unclear
and may possibly support the role of type IV reaction
playing an additional role in the pathogenesis of SLE.
Therefore, in children who present with generalized
lymphadenopathy along with prolonged fever and consti-
tutional symptoms, though uncommon, non-infectious
causes like SLE should also be considered as a diagnostic
possibility.
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